Escherichia coli heat-labile toxin (LT) has also been shown to have negative side effects in humans, as both native and mutant LT (mLT) used as adjuvants were recently associated with the development of Bell's palsy following intranasal delivery in humans [15–17]. Here, LTA is linked to Bell's palsy.